Stocks Health care EVAX
NASDAQ · Health careEvaxion A/S (EVAX)
Evaxion A/S reported revenue of $7.5M in fiscal 2025, up 125.1% from a year earlier. It posted a net loss of $7.7M. In fiscal 2025 capital spending exceeded operating cash flow by $6.6M. At December 31, 2025 it held $23.2M in cash against $5.5M of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 5, 2026.
Watch EVAX in 60 secondsWhat Evaxion A/S does
Evaxion A/S is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker EVAX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $7.5M | -$7.7M | -$0.02 | -$6.6M |
| 2024 | $3.3M | -$10.6M | -$0.20 | -$12.9M |
| 2023 | $73K | -$22.1M | -$0.81 | -$17.8M |
| 2022 | $0 | -$23.2M | -$0.98 | -$26.1M |
| 2021 | n/a | -$24.5M | -$1.26 | -$23.2M |
| 2020 | n/a | -$15M | -$0.97 | -$12.6M |
Full financial statements: income, balance sheet and cash flow
Where EVAX ranks in Health care
Latest SEC filings
What Evaxion A/S has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 14, 2026
- September 4, 2026
- August 20, 2026
- August 20, 2026
- August 17, 2026
- August 14, 2026
- July 17, 2026
- July 13, 2026
- July 1, 2026
- June 12, 2026
Questions about EVAX
What does Evaxion A/S do?
Evaxion A/S is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker EVAX.
Is Evaxion A/S profitable?
No. In fiscal 2025 it reported a net loss of $7.7M on revenue of $7.5M.
How much revenue does Evaxion A/S make?
In fiscal 2025 Evaxion A/S reported revenue of $7.5M. That is 125.1% more than a year earlier.
When did Evaxion A/S last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 5, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 14, 2026.
Similar companies
Compare EVAX with
Follow EVAX
Get an email when Evaxion A/S files with the SEC: results, executive changes, material agreements and annual reports.
Follow EVAX: get an email when it filesWhere the numbers come from
Financial figures are the values Evaxion A/S tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.